01.06.2021
ESM Central Schools: “We are proud of ESM Alum Todd Zion (’93)! He’s the president/CEO Akston Biosciences, which is ramping up efforts for a room temperature COVID-19 vaccine: ‘A vaccine for everywhere & everyone in the world.’
Research and Markets: “Coronavirus Disease 2019 (COVID-19) Vaccines – Contract Development and Manufacturing Landscape”
Hopkinton Independent: “LakePharma announces it will develop, produce COVID vaccine at South Street facility”
Worcester Business Journal: “LakePharma signs partnership to manufacture COVID-19 vaccine candidate in Hopkinton”
Worcester Business Journal on Twitter: “The biotech company LakePharma has signed a partnership agreement with a North Shore therapeutics company to jointly develop a potential COVID-19 vaccine and produce it at its Hopkinton facility”
Grant Welker on Twitter: “The biotech firm LakePharma has signed a partnership agreement with a North Shore therapeutics company to jointly develop a potential COVID-19 vaccine at its Hopkinton facility”
Pharmaceutical Daily: “Akston Biosciences and LakePharma Announce Strategic Partnership to Manufacture Second-Generation COVID-19 Vaccine”
Pharma Focus Asia: “Akston Biosciences and LakePharma Announce Strategic Partnership to Manufacture Second-Generation COVID-19 Vaccine”
World Pharma Today: “Akston Biosciences and LakePharma Enter Covid-19 Partnership”
M2 Pharma: “Akston Biosciences partners with LakePharma to manufacture second-generation COVID-19 vaccine, AKS-452”
M2 Pharma: “Akston Biosciences collaborates with LakePharma to develop commercial quantities of Akston’s COVID-19 vaccine candidate”
Pharmaceutical Business Review: “LakePharma to manufacture Akston Biosciences’ Covid-19 vaccine”
